Dosimetric Comparison of Helical Tomotherapy and HyperArc Treatment Plans for Angiosarcoma of the Scalp
Anticancer Research · 2023
DOI: 10.21873/anticanres.16479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Shoki Inui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan; inui-sy@oici.jp. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Hemangiosarcoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan; inui-sy@oici.jp.
- Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita, Japan.
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Radiology, Osaka International Cancer Institute, Osaka, Japan.
Zitieren
APA
Inui, S., Takahashi, Y., Ueda, Y., Ohira, S., Washio, H., Ono, S., Miyazaki, M., Nishio, T., Koizumi, M., & Konishi, K. (2023). Dosimetric Comparison of Helical Tomotherapy and HyperArc Treatment Plans for Angiosarcoma of the Scalp. Anticancer Research. https://doi.org/10.21873/anticanres.16479
Vancouver
Inui S, Takahashi Y, Ueda Y, Ohira S, Washio H, Ono S, et al. Dosimetric Comparison of Helical Tomotherapy and HyperArc Treatment Plans for Angiosarcoma of the Scalp. Anticancer Research. 2023. doi:10.21873/anticanres.16479
BibTeX
@article{Inui2023,
author = {Inui, Shoki and Takahashi, Yutaka and Ueda, Yoshihiro and Ohira, Shingo and Washio, Hayate and Ono, Shunsuke and Miyazaki, Masayoshi and Nishio, Teiji and Koizumi, Masahiko and Konishi, Koji},
title = {Dosimetric Comparison of Helical Tomotherapy and HyperArc Treatment Plans for Angiosarcoma of the Scalp},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16479}
}
EUVIMED